Squamous Cell Carcinoma And Immunosuppression Risks Overview This study aimed to compare the clinical characteristics and outcomes of cutaneous squamous cell carcinoma (cSCC) in immunosuppressed and immunocompetent patients. The retrospective analysis included 935 cSCC cases, with 19.5% of the patients being immunosuppressed. The study revealed several notable findings: Immunosuppressed patients with
Tag: immune system
